A urine test can help to detect the presence of multiple myeloma by testing for the presence of certain proteins or antibodies in the urine, such as monoclonal light chains. Depending on the type of test used, it may also measure light or heavy chains, or a combination of different antibodies.
The presence of one or more of these antibodies in the urine can suggest the presence of multiple myeloma. Additionally, abnormal blood tests can also help to diagnose multiple myeloma by looking for evidence of anemia, high levels of calcium, or low levels of immunoglobulins.
This combined information can help to confirm a diagnosis of multiple myeloma, as opposed to other types of cancer.
Table of Contents
Can myeloma be detected in urine test?
Yes, a urine test can be used to detect myeloma, but it is not typically the first type of test a doctor will use to make a diagnosis. Myeloma is usually suspected from a blood test that indicates an abnormally high white blood cell count or a high protein level.
If a person has a high white blood count and protein level, their doctor may order a urine test to further assess the possibility of myeloma. Urine tests are used to detect abnormal proteins in the urine, which can be a sign of myeloma.
However, it is important to note that abnormal proteins in the urine does not necessarily mean a person has myeloma and additional tests may be necessary to make a diagnosis. Additionally, a urine test cannot provide a definitive diagnosis of myeloma.
For this, a bone marrow biopsy is typically needed.
Can a urine test detect bone cancer?
No, a urine test cannot detect bone cancer. It is not possible to detect bone cancer through a urine test. In order to diagnose bone cancer, your doctor will need to perform a physical examination, order certain imaging tests (such as an X-ray or an MRI), collect a sample of tissue (through a biopsy or other method), or use a combination of tests.
As part of this process, the doctor might take a blood sample or order lab tests to check for biomarkers associated with cancers or other abnormalities. However, a urine test is not used to diagnose bone cancer because it is not specific enough to detect this kind of cancer.
How do they test for myeloma?
Myeloma is typically tested for via a series of laboratory tests, including a complete blood count (CBC), serum protein electrophoresis (SPE), urine analysis, and a bone marrow biopsy. The CBC will measure the amount of healthy red and white cells, and may indicate if the patient’s myeloma is causing anemia.
The SPE will measure the levels of certain proteins, including monoclonal immunoglobulins, which could indicate myeloma. The urine analysis will measure the levels of monoclonal light chains, which would indicate myeloma.
The bone marrow biopsy is a more definitive test, where a sample of the bone marrow will be removed and examined, looking for the specific cells that indicate myeloma. Additionally, imaging techniques such as x-rays and MRI scans may be used to detect any tumors that may be formed due to myeloma.
When should I suspect myeloma?
If you experience persistent symptoms such as fatigue, anemia, weight loss, frequent bruising or infections, or bone pain and tenderness, you should suspect myeloma and make an appointment to see your doctor.
Other signs of myeloma might include increased urination and difficulty in concentrating. Common combinations of physical symptoms that may merit a suspicion of myeloma include fatigue, frequent or recurring infections, bone pain or tenderness, anemia, and kidney failure.
While myeloma can affect many organs in the body, these symptoms often indicate it has advanced. A full physical examination by your doctor is critical for evaluating whether you may have myeloma, as well as for rule out other diseases.
During the examination, your doctor may also order blood tests, urine tests, and X-rays. Further tests may include bone marrow biopsies or other imaging studies. A diagnosis of myeloma cannot be definitively made without seeing results from a bone marrow biopsy.
What is the abnormal antibody typically found in blood and urine in multiple myeloma?
In multiple myeloma, an abnormal antibody known as a monoclonal immunoglobulin, or M protein, is often found in both the blood and urine. Monoclonal immunoglobulin is a type of antibody produced by cells in the bone marrow called plasma cells.
It is not usually present in the body, and its presence usually indicates the presence of multiple myeloma. This type of antibody is usually identified during a laboratory test called the serum protein electrophoresis, which is used to measure the amount of protein present in the body.
The presence of M protein in the blood or urine can be a sign of multiple myeloma, but its presence does not guarantee a diagnosis or indicate severity of the disease. Other tests, such as a bone marrow biopsy, may be needed to make a definitive diagnosis.
What protein is in urine with myeloma?
Myeloma is a type of cancer that primarily affects plasma cells in the bone marrow. Urine testing can be used as a tool to diagnose and monitor the progression of this type of cancer. In people with myeloma, the urine may be abnormal and identify certain proteins, such as fragments of the monoclonal antibody, an antibody produced by the malignant clone of plasma cells, and Bence Jones protein which is a type of light-chain immunoglobulin protein.
There may also be elevated levels of creatinine, a product of muscle metabolism, and sometimes an elevated BUN, a byproduct of protein breakdown. An analysis of the urine can help to evaluate remission status, provide a baseline for monitoring, and help to determine if an infection may be present.
What would the presence of blood or proteins in urine suggest?
The presence of either blood or proteins in urine usually signals that there may be a medical issue present. Having trace amounts of either is considered normal, however, if levels of blood or proteins are significantly high it can indicate an underlying issue.
Blood in urine, or hematuria, can be caused by urinary tract infections, kidney stones, bladder or kidney cancer, or complications with the bladder—such as bladder tumors, polyps, or an enlarged prostate.
Proteins in urine, or proteinuria, can be caused by kidney damage or disease, including chronic kidney disease, or by certain medications.
It is important to note that blood can be present in the urine without any symptoms, but if proteinuria is present, some additional symptoms may be present, such as foamy urine, general fatigue, abdominal pain, swelling in the feet and ankles, decreased urination, and/or an adverse change in urine color.
If you notice any of these symptoms in addition to the presence of blood or proteins in your urine, it is strongly advised that you consult a doctor for appropriate medical evaluation, investigation, and treatment if necessary.
Does myeloma cause proteinuria?
Myeloma can cause proteinuria, which is a health condition characterized by abnormally high levels of protein in the urine. Proteinuria can be caused by a variety of factors, but it is often the result of inflammation or infection in the kidneys.
Myeloma itself can cause inflammation in the kidneys, which in turn can lead to proteinuria. Additionally, myeloma can damage the filters of the kidneys directly, resulting in proteinuria as they lose the ability to filter proteins as they should.
If a patient has myeloma, it’s important to watch for signs of proteinuria, as long-term, untreated proteinuria can lead to chronic kidney disease and other complications.
Is Bence-Jones protein the same as M-protein?
No, Bence-Jones protein and M-protein are not the same. Bence-Jones protein is a type of immunoglobulin light chain protein associated with multiple myeloma and other conditions. M-protein is an acronym for monoclonal protein, which is a type of protein produced in excess by certain types of plasma cells as a result of a malignant process.
It can be either of two types of immunoglobulins, known as IgG or IgA. It is not uncommon to measure both Bence-Jones protein and M-protein levels in a person with multiple myeloma, as they are often present in elevated amounts in the blood of people with this condition.
The presence of high Bence-Jones protein levels can provide an indication of the development of multiple myeloma, while an increased level of M-protein can provide evidence of an already existing case of the disease.
Which 3 laboratory markers are involved in the staging and prognosis of multiple myeloma?
The three laboratory markers most commonly used to stage and prognosis multiple myeloma are the serum protein electrophoresis (SPEP), the immunofixation electrophoresis (IFE), and the β-2-microglobulin (B2M) levels.
SPEP measures the concentration of different proteins found in the blood and helps to identify a myeloma protein as monoclonal (meaning abnormally high levels of a single protein) versus polyclonal (abnormally high levels of multiple proteins).
IFE is used to confirm and identify the protein present in SPEP as monoclonal in origin. The B2M is a protein produced by the myeloma cells and its levels are an indicator of the amount of myeloma cells in the body and consequently its stage.
Higher levels tend to suggest a worse prognosis.
